Table 1.
Clinical characteristics of 583 glioma patients from The Cancer Genome Atlas (TCGA) cohort included in this study.
| Variables | Number (%) |
|---|---|
| Vital status | |
| Alive | 370 (63.46%) |
| Dead | 213 (36.54%) |
| Age | |
| <60 | 460 (78.90%) |
| ≥60 | 123 (21.10%) |
| Sex | |
| Female | 248 (42.54%) |
| Male | 335 (57.46%) |
| Tumor grade | |
| WHO II | 224 (38.42%) |
| WHO III | 238 (40.82%) |
| WHO IV | 121 (20.76%) |
| Molecular subtypes | |
| IDH mutant and 1p/19q codeletion (LGG) | 145 (24.87%) |
| IDH mutant and 1p/19q non-codel (LGG) IDH wildtype (LGG) IDH mutant (GBM) IDH wildtype (GBM) |
234 (40.14%) 80 (13.73%) 7 (1.20%) 101 (17.32%) |
| Others | 16 (2.74%) |
LGG, lower-grade glioma; GBM, glioblastoma.